Furthermore, as mentioned, there is not necessarily a direct correlation between STING activation and anti-cancer activity as higher concentrations of the STING-activating molecule ADU-S100 drove less immunogenic responses [93], and robust STING activation is lethal to some immune cells [94]. Here, STING1 is linked to cancer.